OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, today announced it ...
DELRAY BEACH, Fla., Oct. 30, 2025 /PRNewswire/ — According to MarketsandMarkets™, the global Consumer IAM Market size is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback